Cargando…
UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?
Autores principales: | Husein, Melisa, Petignat, Patrick, Cohen, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174630/ https://www.ncbi.nlm.nih.gov/pubmed/37182093 http://dx.doi.org/10.18632/oncoscience.575 |
Ejemplares similares
-
The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014) -
Linking unfolded protein response to ovarian cancer cell fusion
por: Yart, Lucile, et al.
Publicado: (2022) -
GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach
por: Delie, Florence, et al.
Publicado: (2012) -
Acellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells
por: Cohen, Marie, et al.
Publicado: (2014) -
Aging, MnSOD, and hormesis mechanisms converge on liver mUPR
por: Shen, Jie, et al.
Publicado: (2013)